The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,640.00
Bid: 1,637.50
Ask: 1,638.00
Change: -10.50 (-0.64%)
Spread: 0.50 (0.031%)
Open: 1,650.50
High: 1,658.50
Low: 1,627.50
Prev. Close: 1,650.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Natwest posts 2021 profit, plans share buyback

Fri, 18th Feb 2022 07:46

(Alliance News) - Stocks in London are set to steady on Friday at the end of a difficult week dominated by headlines about the Russia-Ukraine crisis.

In early UK economic data, the retail sector rebounded at the start of 2022 after a disappointing Omicron-hit December. UK retail sales rose 1.9% year-on-year in January after a 4.0% fall in December.

Sales were 3.6% above pre-pandemic levels at the start of 2022.

"It was a good month for garden centres, department and household goods stores, with particularly strong trading for furniture and lighting," said Darren Morgan, director of Economic Statistics at the Office for National Statistics.

Sterling was quoted at USD1.3625 early Friday, firm against USD1.3620 at the London equities close on Thursday.

In early company news, lender Natwest unveiled a GBP750 million share buyback programme as it swung to profit in 2021, and industrial property investor Segro topped net asset value forecasts.

IG says futures indicate the FTSE 100 index of large-caps to open up 15.73 points, or 0.2%, at 7,553.10 on Friday. The FTSE 100 closed down 66.41 points, or 0.9%, at 7,537.37 on Thursday.

"Yesterday saw another day of uncertainty and market declines on claims and counterclaims between Russia and NATO about the size and movement of Russian forces on the Ukrainian border," said Michael Hewson, chief market analyst at CMC Markets.

The US said Thursday that Russia is on the verge of unleashing a massive military attack against Ukraine, dismissing Moscow's claim to be pulling forces back, as artillery fire hit a Ukrainian kindergarten.

In a dramatic, previously unscheduled speech to the United Nations in New York, US Secretary of State Antony Blinken said intelligence showed Moscow could order an assault on its neighbour in the "coming days".

Russia denies any invasion plans but warned of "military-technical measures" if its far-reaching demands for a US and NATO pullback from eastern Europe aren't satisfied.

Investor sentiment took a hit from this in New York overnight, with the Dow Jones Industrial Average ending down 1.8%, the S&P 500 down 2.1%, and the Nasdaq Composite down 2.9%.

Losses moderated in the Asian session on Friday, however. The Nikkei 225 index in Tokyo closed down 0.4%. In China, the Shanghai Composite ended up 0.7%, but the Hang Seng index in Hong Kong was down 1.7% in late trade. The S&P/ASX 200 in Sydney fell 1.0%.

The US said late Thursday that Blinken and his Moscow counterpart Sergei Lavrov had agreed to meet next week – provided there was no invasion before then.

"This development looks set to see markets here in Europe open modestly higher on the basis that if the US and Russia continue to talk then the prospect of war has diminished for the time being," CMC's Hewson said.

In early UK company news, NatWest reported a profit for 2021 and said it plans to return GBP750 million to shareholders via a share buyback, and possibly even more.

Net interest income for 2021 rose 1.7% to GBP7.61 billion from GBP7.48 billion the year before, though a dip in non-interest income meant total income for the year was flat at GBP10.51 billion.

The lender swung to a pretax profit of GBP4.03 billion from a loss of GBP481 million the year before, benefiting from an impairment release of GBP1.28 billion versus an expense of GBP3.13 billion.

The impairment release "principally reflects releases in non-default portfolios and the low levels of realised losses we have seen across the year," the bank said.

Natwest laid out plans for a GBP750 million share buyback in the first half of 2022 and said it will consider further repurchases as part of its capital distribution approach. This was alongside a final dividend of 7.5p, more than double 3.0p the year before.

The state-controlled lender also said it will maintain capacity to participate in buybacks of shares held by the UK government.

For 2022, Natwest expects income excluding notable items to be above GBP11.0 billion in the 'go-forward group' - which excludes Ulster Bank RoI and discontinued operations - and it plans to invest around GBP3 billion over 2021 to 2023 while reducing operating costs.

"As our economy recovers and the trend towards digital services accelerates, we are investing to deliver long term value in the bank and drive sustainable growth. We will do this by building closer and deeper relationships with our customers and by supporting their evolving needs and expectations at every stage of their lives," said Chief Executive Alison Rose.

Warehouse property investor Segro reported an adjusted net asset value per share of 1,137 pence at the end of 2021, up 40% from 814p a year before. This beat company-compiled consensus of 998p.

Pretax profit for 2021 multiplied to GBP4.36 billion from GBP1.46 billion in 2020.

"2021 was a highly successful year for Segro as reflected in our full year results which include a GBP4.1 billion portfolio valuation uplift and record levels of rental growth. Investor and occupier supply-demand dynamics in the industrial and logistics sector remain very favourable, led by the long-term trends of digitalisation, supply chain resilience and an increasing focus on sustainability," said Chief Executive David Sleath.

GlaxoSmithKline said it has voluntarily paused enrolment and vaccination in the Grace phase three trial evaluating its potential respiratory syncytial virus maternal vaccine candidate, as well as two other trials investigating this candidate in pregnant women.

"This decision was made following a recommendation from the Independent Data Monitoring Committee based on an observation from a routine safety assessment. Monitoring safety signals is an integral part of the clinical development process for potential new vaccines," the pharmaceutical firm said, adding it will provide a further update in due course.

This decision does not affect the AReSVi 006 phase three trial for RSV older adults, with results from this study on track for the first half of 2022.

NortonLifeLock said it has postponed the closing of its merger with Avast to April, having been previously expected to close later this month.

NortonLifeLock said talks with competition bodies in the UK and Spain are ongoing. As a result of the delay, Avast said it plans to proceed with the payment of a 11.2 cent dividend. The closing is expected to be on April 4, delayed from February 24, with Avast shares delisted on April 5.

The euro traded at USD1.1372 early Friday, unchanged versus USD1.1370 late Thursday.

Against the yen, the dollar edged up to JPY115.06 from JPY115.02. The yen eased after data showed Japan's core consumer prices edged up just 0.2% in January, slightly less than expected, though the increase was the fifth monthly rise.

The core consumer price index, which excludes volatile fresh food prices but includes fuel costs, was up 0.2% in January year-on-year, following similar rises from September to December. The advance follows 18 months of declines or stagnation during the depths of the pandemic, but it fell slightly short of economist expectations for a 0.3% rise.

Safe-haven asset gold softened as risk mood improved into the end of the week. The shining metal was quoted at USD1,891.83 an ounce early Friday, lower than USD1,895.50 on Thursday.

Brent oil was trading at USD92.41 a barrel early Friday, soft on USD92.65 late Thursday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.